Phage therapy program
Qeen Biotechnologies
| Status | Provider-listed inquiry route |
|---|---|
| Type | Supplier |
| Location | Gatineau, Québec; Canada |
| Entry review | 2026-10-04 |
Access and enquiries
| How to enquire | Qeen’s Patient Access page offers a form to ask about providing or manufacturing bacteriophages for serious bacterial infections when treatment options are exhausted. This is a supplier inquiry, not a treating clinic or a guarantee of eligibility, supply or regulatory authorization. |
|---|---|
| Areas of work | Tailored phage development, manufacture, characterization, quality control and regulatory consultation. Institutional P-PEAKS announcement names Qeen as one of three manufacturers. |
| International access | No public international-patient eligibility or acceptance policy verified. |
What to confirm
- Supplier contact is not evidence of current direct patient acceptance. Public marketing certifications were not independently validated.
- The patient inquiry form does not confirm country-specific eligibility or current treatment availability; discuss any proposed use with the treating team.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | qeen |
|---|